AU2021233784A1 - Compositions and methods for naloxone delivery - Google Patents

Compositions and methods for naloxone delivery

Info

Publication number
AU2021233784A1
AU2021233784A1 AU2021233784A AU2021233784A AU2021233784A1 AU 2021233784 A1 AU2021233784 A1 AU 2021233784A1 AU 2021233784 A AU2021233784 A AU 2021233784A AU 2021233784 A AU2021233784 A AU 2021233784A AU 2021233784 A1 AU2021233784 A1 AU 2021233784A1
Authority
AU
Australia
Prior art keywords
compositions
methods
naloxone
delivery
naloxone delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021233784A
Inventor
Haiyong Hugh Huang
Manjunath S. Shet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Pharma LP
Original Assignee
Purdue Pharma LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma LP filed Critical Purdue Pharma LP
Publication of AU2021233784A1 publication Critical patent/AU2021233784A1/en
Pending legal-status Critical Current

Links

AU2021233784A 2020-03-11 2021-02-26 Compositions and methods for naloxone delivery Pending AU2021233784A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/988,161 2020-03-11

Publications (1)

Publication Number Publication Date
AU2021233784A1 true AU2021233784A1 (en) 2022-09-22

Family

ID=

Similar Documents

Publication Publication Date Title
EP4114939A4 (en) Oligonucleotide compositions and methods thereof
EP3989746A4 (en) Tobacco product compositions and delivery system
EP4132589A4 (en) Compositions and methods for blood-brain barrier delivery
EP3946547A4 (en) Devices and methods for delivering pharmaceutical compositions
EP4114360A4 (en) Compositions and methods for targeted rna delivery
EP4136254A4 (en) Ace2-targeted compositions and methods for treating covid-19
EP3982932A4 (en) Compositions and methods for biological delivery vehicles
EP4153567A4 (en) Methods and compositions for targeting pd-l1
EP3817734A4 (en) Composition and method for opioid sparing
EP3908251A4 (en) Pharmaceutical delivery compositions and uses thereof
EP3982942A4 (en) Drug delivery methods and compositions
EP4138879A4 (en) Methods and compositions
EP4117629A4 (en) Compositions and methods for naloxone delivery
EP4084784A4 (en) Compositions and methods
EP4114176A4 (en) Sterilization compositions and methods for using thereof
EP3876938A4 (en) Compositions and methods for opioid antagonist delivery
AU2022342169A1 (en) Hbb-modulating compositions and methods
AU2022344251A1 (en) Serpina-modulating compositions and methods
AU2021233784A1 (en) Compositions and methods for naloxone delivery
EP4100471A4 (en) Mucoadhersive polymeric drug delivery compositions and methods
EP4100523A4 (en) Compositions and methods for circular rna expression
EP4149262A4 (en) Compositions and methods for antimicrobial articles
EP4015516A4 (en) Benzofuran-based n-acylhydrazone derivative and pharmaceutical composition comprising same
EP3973003A4 (en) Compositions and methods for cellular delivery
AU2022342168A1 (en) Pah-modulating compositions and methods